Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort Yousef Almahanna; Francisco Idalsoaga; Luis Antonio Díaz; Ahmed Almohsen; Yi Nong Song; Amani Bajunayd; Rokhsana Mortuza; Jeemin Kim; Adrienne Abaya; Mohammad Qasim Khan; Juan Pablo Arab;

Development and external validation of a machine-learning based model to predict pre-sarcopenia in MASLD population: Results from NHANES 2017¿2018 Siwei Yang; Jianan Yu; Qiyang Chen; Xuedong Sun; Yuefeng Hu; Tianhao Su; Jian Li; Long Jin;

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;